AmerisourceBergen to pay $625M over illegally repackaged drugs
AmerisourceBergen and its subsidiaries have agreed to pay $625 million to resolve its civil liability to the United States under the False Claims Act for causing false claims for the drugs it repackaged to be submitted to federal health care programs.
Related articles
-
ArticleLarge wound care practice pays $45M, agrees to monitoring
One of the largest wound care practices in the nation and its founder have agreed to pay $45 million and be subjected to third-party monitoring, to settle allegations that the business intentionally overbilled Medicare by priming its electronic medical records system to do so.
-
ArticleFormer CEO of steel pipe maker indicted for allegedly defrauding investors of $66M
A former chief executive of a large steel pipe manufacturer has been accused by the Department of Justice (DOJ) of defrauding more than $66 million from a bank and investors.
-
ArticleRussian web company that hosted LockBit ransomware sanctioned
Two Russian web-hosting services that provide cover for ransomware operators, including Lockbit, have been sanctioned by the U.S. Treasury’s OFAC and international partners.